Developed for a variety of pharmaceutical applications involving in vitro filtration, wicking, venting and controlled release mechanisms, the moulding technology allows for rapid prototyping thereby reducing project time and time to market, the firm says. The new cleanroom based manufacturing process does not require expensive tooling and is automated to reduce potential contamination and bioburden.
Available in sheet, tube and almost any 3D shape in pore sizes from 10–100 micron, Porvair Filtration Group's sintered porous plastic materials are FDA and WRAS approved, easily cleanable, strong, rigid and self-supporting with a long life expectancy and high resistance to chemicals. An ISO 9001-2000 quality assurance programme underpins the manufacturing of these materials for OEM customers.